Bucindolol hydrochloride

N/A

Report date: 2024/09/04 13:35:01
NME

Base Information

Drug NameBucindolol hydrochloride
Drug Alias Name盐酸布新洛尔bucindololum布新洛尔盐酸盐布新洛尔Gencaro +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta adrenergic receptors antagonists
TargetsBeta adrenergic receptors
Therapy Area/IndicationsHeart FailureAtrial FibrillationHeart Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPoland +[6] 
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesArca Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArca Biopharma IncNational Heart, Lung, And Blood Institute (Nhlbi)
Active IndicationsN/A
Inactive IndicationsHeart FailureAtrial FibrillationHeart Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG